Stay updated on Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Sign up to get notified when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.

Latest updates to the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page
- Check4 days agoChange DetectedRevision: v3.5.2 replaces v3.5.0.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded the 2026 Neurol Ther publication detailing EMBARK two-year outcomes and updated the revision to v3.5.0; the older online-ahead-of-print citation and its previous revision (v3.4.3) were removed.SummaryDifference0.1%

- Check40 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded a 2026 Neurol Ther publication by Audhya et al. on caregiver-reported experiences with Delandistrogene Moxeparvovec in EMBARK and removed the 2025 online-ahead-of-print Neurol Ther article.SummaryDifference0.0%

- Check68 days agoChange DetectedMinor site-wide updates were made, including adding revision v3.4.2 and removing notices about funding lapse and revision v3.4.1. These changes do not affect study data, eligibility, or user actions on the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check75 days agoChange DetectedAdded a government funding lapse notice with operating status details and updated the site version to Revision: v3.4.1, removing the previous v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.